The 54 references in paper V. Dobronravov A., A. Smirnov V., A. Bezrukikh M., N. Bystrova N., Yu. Drozdova V., S. Orlova A., В. Добронравов А., А. Смирнов В., А. Безруких М., Н. Быстрова Н., Ю. Дроздова В., С. Орлова А. (2006) “АНЕМИЯ И ПРЕДДИАЛИЗНЫЕ СТАДИИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК: КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ, РАСПРОСТРАНЕННОСТЬ И ФАКТОРЫ РИСКА // ANEMIA AND PRE-DIALYSIS STAGES OF CHRONIC KIDNEY DISEASE: CLINICAL SIGNIFICANCE, INCIDENCE AND RISK FACTORS” / spz:neicon:nefr:y:2006:i:3:p:7-13

1
Locatelli F, Valderrabano F, Hoenich N et al. Progress in dialysis technology: membrane selection and patient outcome. Nephrol Dial Transplant 2000; 15: 1133-1139
(check this in PDF content)
2
United States Renal Data System, 2002 Annual Data Report. Am J Kidney Dis 2003; 41(4) [suppl. 2]: s41-56
(check this in PDF content)
3
Nissenson AR, Pereira BJ, Collins AJ, Steinberg EP. Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis 2001; 37(6):1177-1183
(check this in PDF content)
4
Obrador GT, Pereira BJ, Kausz AT Chronic kidney disease in the United States: an underrecognized problem. Semin Nephrol 2002; 22(6): 441-448
(check this in PDF content)
5
Nickolas TL et al. Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis 2004; 44(2):185-197
(check this in PDF content)
6
McGill JB. Kidney Early Evaluation Program (KEEP). Findings from a community screening program. Diabetes Educ 2004; 30(2):196-198
(check this in PDF content)
7
Verhave JC et al. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int 2004; 66 (s92): S18-21
(check this in PDF content)
8
Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41(1):1-12
(check this in PDF content)
9
Смирнов АВ, Добронравов ВА, Бодур-Ооржак АШ и др. Эпидемиология и факторы риска хронической болезни почек: региональный уровень общей проблемы. Тер архив 2005; в печати
(check this in PDF content)
10
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 [Suppl 3]:S112-S119
(check this in PDF content)
11
Stevens LA, Levin A. Anaemia, cardiovascular disease and kidney disease: Integrating new knowledge in 2002. Curr Opin Nephrol Hypertens 2003;12(2):133138
(check this in PDF content)
12
Adler AI, Stevens RJ, Manley SE et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63(1):225-232
(check this in PDF content)
13
Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 2003;16(2):101-105
(check this in PDF content)
14
Manjunath G, Tighiouart H, Coresh J et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63(3):1121-1129
(check this in PDF content)
15
Mann JF, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001;134(8):629-636
(check this in PDF content)
16
Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 2002;106(14):1777-1782
(check this in PDF content)
17
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108(17):2154- 2169
(check this in PDF content)
18
Go A, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. NEJM 2004; 351(13):1285-1295
(check this in PDF content)
19
Herzog CA, Puumala M, Collins AJ. NHANES III: The distribution of hemoglobin levels related to chronic kidney disease (CKD), diabetes (DM), and congestive heart failure (CHF). J Am Soc Nephrol 2002;13: 428A
(check this in PDF content)
20
Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999;10(3):610619
(check this in PDF content)
21
McClellan WM, Flanders WD, Langston RD et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. J Am Soc Nephrol 2002; 13(7):1928-1936
(check this in PDF content)
22
Parfrey PS, Foley RN, Harnett JD et al. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11(7):12771285
(check this in PDF content)
23
Astor BC, Muntner P, Levin A et al. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (19881994). Arch Intern Med 2002; 162(12): 1401-1408
(check this in PDF content)
24
Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002; 13(2): 504-510
(check this in PDF content)
25
Obrador GT, Roberts T, St. Peter WL et al. Trends in anemia at initiation of dialysis in the United States. Kidney Int 2001; 60(5):1875-1884
(check this in PDF content)
26
Obrador GT, Ruthazer R, Arora P et al. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 1999; 10(8):1793- 1800
(check this in PDF content)
27
Jungers PY, Robino C, Choukroun G et al. Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: A prospective study in 403 patients. Nephrol Dial Transplant 2002; 17(9):1621-1627
(check this in PDF content)
28
Jurkovitz CT, Abramson JL, Vaccarino VL et al. Is the association between renal function and risk of developing coronary heart disease modified by hemoglobin status? Results from the Prospective Community-Based Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol 2002;13: 434A
(check this in PDF content)
29
Collins AJ, Li S, St. Peter WL et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 2001; 12(11):2465-2473
(check this in PDF content)
30
Keith D, Nichols G, Gullion C et al. Mortality of chronic kidney disease (CKD) in a large HMO population. J Am Soc Nephrol 2002;13: 620A
(check this in PDF content)
31
Foley RN, Parfrey PS, Harnett JD et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end- stage renal disease. Am J Kidney Dis 1996; 28(1):53-61
(check this in PDF content)
32
Harnett JD, Foley RN, Kent GM et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995;47(3):884-890
(check this in PDF content)
33
Silverberg D, Blum M, Peer G, Iaina A. Anemia during the predialysis period: A key to cardiac damage in renal failure. Nephron 1998; 80(1):1-5
(check this in PDF content)
34
London GM, Pannier B, Guerin AP et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol 2001;12(12):2759-2767
(check this in PDF content)
35
Levin A, Thompson C, Ethier J et al. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 1999;34: 125-134
(check this in PDF content)
36
Gilbertson DT, Li SL, Murray A et al. The competing risks of death vs. ESRD in Medicare beneficiaries 65+with chronic kidney disease, CHF, and anemia. J Am Soc Nephrol 2002;13: 439A
(check this in PDF content)
37
Portoles J, Torralbo A, Martin P et al. Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 1997; 29: 541-548
(check this in PDF content)
38
Hayashi T, Suzuki A, Shoji T et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 2000; 35: 250-256
(check this in PDF content)
39
Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66(2):753-760
(check this in PDF content)
40
Deicher R, Horl WH. Anaemia as a risk factor for the progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2003;12(2):139-143
(check this in PDF content)
41
Ueda H, Ishimura E, Shoji T et al. Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 2003; 26(5):1530-1534
(check this in PDF content)
42
Iseki K, Ikemiya Y, Iseki C, Takishita S. Haematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transplant 2003;18: 899-905
(check this in PDF content)
43
Keane WF, Brenner BM, De Zeeuw D et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy. The RENAAL Study. Kidney Int 2003; 63(4): 1499-1507
(check this in PDF content)
44
Cusick M et al. Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26. Kidney Int 2004; 66(3):1173-1179
(check this in PDF content)
45
Jungers PY, Choukroun G, Oualim Z et al. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 2001;16(2): 307-312
(check this in PDF content)
46
Becker BN, Becker YT, Leverson GE, Heisey DM: Erythropoietin therapy may retard progression in chronic renal transplant dysfunction. Nephrol Dial Transplant 2002; 17(9): 1667-1673
(check this in PDF content)
47
Kuriyama S, Tomonari H, Yoshida H et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 1997; 77(2):176-185
(check this in PDF content)
48
The US Recombinant Human Erythropoietin Predialysis Study Group: Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis 1991;18(1):50-59
(check this in PDF content)
49
Krmar RT, Gretz N, Klare B et al. Renal function in predialysis children with chronic renal failure treated with erythropoietin. Pediatr Nephrol 1997;11(1):69-73
(check this in PDF content)
50
Clyne N, Jogestrand T. Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients. Nephron 1992; 60(4):390-396
(check this in PDF content)
51
Eschbach JW, Kelly MR, Haley NR et al. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989;321(3):158-163
(check this in PDF content)
52
Smith RD, Schulman G et al.Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 1994;24(5):777-784
(check this in PDF content)
53
Lim VS, DeGowin RL, Zavala D et al. Recombinant human erythropoietin treatment in pre-dialysis patients. A double­ blind placebo-controlled trial. Ann Intern Med 1989; 110(2): 108-114 55. Abraham PA, Opsahl JA, Rachael KM et al. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. Am J Nephrol 1990;10(2):128-136 56. Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 2000;75: S22-S26 57. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000; 58(6): 2351-2366 58. Mazzali M, Jefferson JA, Vaziri ND, J
(check this in PDF content)
54
877-884 64. Erslev AJ. Erythropoietin. N Engl J Med 1991; 324:1339­ 1344 65. Ross R, McCrea J, Besarab A. Erythropoietin response to blood loss in hemodialysis patients is blunted but preserved.
(check this in PDF content)